FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and Peptides, Drugs And Supplements: Science, Risks, And Alternatives Los Angeles Times The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions Analysis: The peptide problem: Hype is outrunning the evidence McMaster News